Blood test to guide next cancer treatment choices
Part of Cancer clinical trials.
This study checks whether a blood test can find tumor genetic changes (called “plasma genomic profiling”) to help choose the best next treatment. It may help your care team decide therapy after your cancer progresses or seems likely to progress soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your health status should be good enough for daily activities (ECOG 0–1).
- You have a solid tumor type such as esophageal cancer, non-adenocarcinoma lung cancer, small-cell lung cancer, head & neck cancer, mesothelioma, breast cancer, or lung neuroendocrine cancer.
- You can provide blood samples at key times: about 20–30 mL at baseline, again within 1–3 weeks after starting treatment, at the first scan, and again at progression.
- You may need archived or recent tumor tissue, but this is preferred—not required—and must be enough for testing if you have it.
- Your cancer should be able to be tracked for change over time (you don’t need “measurable” tumors).
- You can sign consent, and you are not pregnant (women who are known to be pregnant cannot join).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test (liquid biopsy) to find genetic changes in advanced solid tumors. It may help doctors choose the right treatment and monitor how well it works over time.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study looks at whether a simple blood test (called liquid biopsy) can help monitor how well your cancer treatment is working. By checking for tumor DNA in your blood before and during treatment, researchers hope to see if the treatment is effective and if the cancer is responding, which could help guide your care.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.